Your browser doesn't support javascript.
loading
Early Onset of Severe Interstitial Pneumonitis Associated With Anti-PD-1 Immune Checkpoint Antibody After Pleurodesis.
Haga, Sanshiro; Sekine, Akimasa; Hagiwara, Eri; Kaneko, Taichi; Ogura, Takashi.
Afiliação
  • Haga S; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JPN.
  • Sekine A; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JPN.
  • Hagiwara E; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JPN.
  • Kaneko T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JPN.
  • Ogura T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JPN.
Cureus ; 16(4): e58798, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38784310
ABSTRACT
We present a case of lung adenocarcinoma with malignant pleural effusion. Nineteen days after pleurodesis using minocycline and OK-432 (picibanil), pembrolizumab monotherapy was initiated. Four days later, the patient experienced a persistent cough. Chest computed tomography showed that ground-glass opacity appeared on the same side as pleurodesis and spread bilaterally thereafter, which was diagnostic of immune checkpoint inhibitors (ICI)-related pneumonitis. As he presented a severe respiratory failure, corticosteroid therapy was administered. Two weeks later, respiratory failure completely resolved and the abnormal shadows dramatically improved. Our results indicate that severe ICI-related pneumonitis can develop within a short period after pleurodesis.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article